Navigation Links
Defense Appropriations Funding Will Advance STB(R)'s Development of Lifesaving Dressing

ROCKVILLE, Md., Feb. 23 /PRNewswire/ -- STB Lifesaving Technologies® announced today $2.4 million was included in the FY2010 U.S. Department of Defense appropriations bill to advance the development of the Fibrin Adhesive STat (FAST®) dressing. This newly developed dressing is designed to be effective against all kinds of blood loss, including severe arterial and venous bleeding and could help save the lives of soldiers suffering from severe blood loss.

According to the Combat Casualty Care Research Program, eighty-six percent of combat-related deaths occur within 30 minutes of wounding, and fifty percent or more are attributable to uncontrolled hemorrhaging.  With better products to control bleeding, such as the STB FAST® dressing, thousands of military and civilian lives could be saved.

"We are grateful for Senator Cardin's continued support for STB® and honored by the opportunity to serve the Department of Defense. If awarded to STB®, these funds, along with funds provided by our investors, will be used to accelerate the step up to cGMP manufacturing, and the necessary planning and pre-clinical work required to file for approval by the FDA to initiate human clinical trials," said Ron Peele, STB®'s President.  

Much of the clinical planning will involve advisors from the University of Maryland and MD Shock Trauma Center, who will also be involved in the in vivo efficacy testing, which will be conducted at a facility in Reisterstown, MD.

About STB®  

Founded in 2005, STB Lifesaving Technologies® (STB®) is a privately held, pre-clinical stage, biotechnology development company located in Rockville, Maryland. STB® which stands for "stop the bleeding", is focused on developing a comprehensive suite of products to stop serious and life threatening bleeding in trauma and surgical settings. With a strong proprietary position using its all-natural protein technology with five patents and one provisional patent pending, STB®'s products will be indispensable to both the military and civilian medical markets.

SOURCE STB Lifesaving Technologies

Back to top



SOURCE STB Lifesaving Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
3. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
4. Saft Develops Super-Phosphate(TM) Technology for Rigorous Defense Applications
5. U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain
6. Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan
7. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
8. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
9. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
10. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
11. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):